CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Oncoimmunology

• Publication date

  2016-03-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/2162402X.2016.1151594PMID 27471622PMCID PMC4938362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma

  2015cited by this paper
• CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.

  2015cited by this paper
• Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration.

  2015influential reference
• Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer—review of current data.

  2015cited by this paper
• Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma

  2015cited by this paper
• Macrophages and cancer: from mechanisms to therapeutic implications.

  2015cited by this paper
• Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade.

  2015cited by this paper
• IL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer

  2015cited by this paper
• Immune checkpoint blockade: a common denominator approach to cancer therapy.

  2015influential reference
• Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma

  2015cited by this paper
• Novel insights into head and neck cancer using next-generation "omic" technologies.

  2015cited by this paper
• J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

  2014cited by this paper
• Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma.

  2014influential reference
• The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies

  2014cited by this paper
• The origin and function of tumor-associated macrophages

  2014cited by this paper
• CD163+ Tumor-Associated Macrophages Correlated with Poor Prognosis and Cancer Stem Cells in Oral Squamous Cell Carcinoma

  2014cited by this paper
• Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma

  2014cited by this paper
• Tumor associated macrophages and neutrophils in cancer.

  2013cited by this paper
• Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.

  2013cited by this paper
• Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

  2013cited by this paper
• T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development.

  2013cited by this paper
• History of myeloid-derived suppressor cells

  2013cited by this paper
• Post-interventional atherosclerotic vascular remodeling : preclinical investigation into immune-modulatory therapies

  2013cited by this paper
• Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer

  2013cited by this paper
• The Immune Signature of CD8+CCR7+ T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC

  2012cited by this paper
• Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer

  2012cited by this paper
• Chemopreventive and Chemotherapeutic Actions of mTOR Inhibitor in Genetically Defined Head and Neck Squamous Cell Carcinoma Mouse Model

  2012influential reference
• Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms

  2012cited by this paper
• Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation

  2012cited by this paper
• Myeloid-derived suppressor cells in transplantation and cancer

  2012cited by this paper
• Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

  2011influential reference
• The molecular biology of head and neck cancer

  2011cited by this paper
• Cancer: Re-educating tumour-associated macrophages

  2011cited by this paper
• Improved survival with ipilimumab in patients with metastatic melanoma.

  2010cited by this paper
• Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma

  2010cited by this paper
• PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention

  2009cited by this paper
• Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.

  2009cited by this paper
• CD28 and CTLA‐4 coreceptor expression and signal transduction

  2009cited by this paper
• Macrophage polarization in tumour progression.

  2008cited by this paper
• Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

  2007cited by this paper
• Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.

  2006influential reference
• CTLA-4: new insights into its biological function and use in tumor immunotherapy

  2002cited by this paper
• CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.

  1996cited by this paper
• Enhancement of Antitumor Immunity by CTLA-4 Blockade

  1996influential reference
• Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

  1995cited by this paper
• Molecular biology of head and neck cancer.

  1994cited by this paper
• Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

  1994cited by this paper
• CTLA-4 can function as a negative regulator of T cell activation.

  1994cited by this paper
• Properties of the novel proinflammatory supergene "intercrine" cytokine family.

  1991cited by this paper

• IMMUNOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: THE CURRENT STATUS AND FUTURE OUTLOOK.

  2026cites this paper
• Prognostic Utility of Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) Expression in Head and Neck Squamous Cell Carcinoma: A Retrospective Study

  2025cites this paper
• Harnessing Macrophages in Cancer Therapy: from Immune Modulators to Therapeutic Targets

  2025cites this paper
• Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance

  2025cites this paper
• Sex-Specific Transcriptomic Effects of Low-Dose Inorganic Arsenic Exposure on Bone Marrow-Derived Macrophages.

  2024cites this paper
• Identification and validation of a prognostic model based on three TLS-Related genes in oral squamous cell carcinoma

  2024cites this paper
• Overall survival prediction of gastric cancer using the gene signature of CT-detected extramural venous invasion combined with M2 macrophages infiltration

  2024cites this paper
• Toxicity in the era of immune checkpoint inhibitor therapy

  2024cites this paper
• Machine learning developed a macrophage signature for predicting prognosis, immune infiltration and immunotherapy features in head and neck squamous cell carcinoma

  2024cites this paper
• Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma

  2024cites this paper
• Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma

  2024cites this paper
• Immunotherapy for Head and Neck Squamous Cell Carcinoma: Present and Future Approaches and Challenges.

  2024cites this paper
• Verification of the expression trend and interaction prediction of innate immune cells and immune-checkpoint molecules in the process of oral mucosal carcinogenesis.

  2024cites this paper
• TIM3 and CTLA4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia

  2024cites this paper
• Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma.

  2024cites this paper
• Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

  2024cites this paper
• The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers.

  2024cites this paper
• Transcriptomic Effects of Low-Dose Inorganic Arsenic Exposure on Murine Bone Marrow-Derived Macrophages

  2023cites this paper
• The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas

  2023cites this paper
• Targeting M-MDSCs enhances the therapeutic effect of BNCT in the 4-NQO-induced murine head and neck squamous cell carcinoma model

  2023cites this paper
• NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma

  2023cites this paper
• Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Immunomodulatory Properties of Immune Checkpoint Inhibitors—More than Boosting T-Cell Responses?

  2022cites this paper
• Comparison of the Effectiveness of IgG Antibody versus F(ab')2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy.

  2022cites this paper
• MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma

  2022cites this paper
• The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy

  2022cites this paper
• Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy

  2022cites this paper
• Rethinking immune checkpoint blockade: ‘Beyond the T cell’

  2021cites this paper
• Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy

  2021cites this paper
• Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End

  2021cites this paper
• Tumor-Infiltrating Immune-Related Long Non-Coding RNAs Indicate Prognoses and Response to PD-1 Blockade in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

  2021cites this paper
• Molecular Subtypes of Oral Squamous Cell Carcinoma Based on Immunosuppression Genes Using a Deep Learning Approach

  2021cites this paper
• Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

  2021cites this paper
• Cetuximab in locally advanced head and neck squamous cell carcinoma: biological mechanisms involved in efficacy, toxicity and resistance.

  2021cites this paper
• Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types

  2020cites this paper
• Resistance to Checkpoint Inhibition in Cancer Immunotherapy

  2020cites this paper
• Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma

  2020cites this paper
• The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy

  2020cites this paper
• Immunosurveillance and mechanisms of immune escape in head and neck cancer

  2020cites this paper
• Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer

  2020influential citation
• Corn-like Au/Ag nanorod-mediated NIR-II photothermal/photodynamic therapy potentiates immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment.

  2020cites this paper
• Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma

  2019cites this paper
• Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy.

  2019cites this paper
• The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma

  2019cites this paper
• A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells

  2019cites this paper
• Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells

  2019cites this paper
• MIXTURE: an improved algorithm for immune tumor microenvironment estimation based on gene expression data

  2019cites this paper
• Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma

  2019cites this paper
• Co-inhibitory immune checkpoints in head and neck squamous cell carcinoma.

  2018cites this paper
• Progress in Tumor‐Associated Macrophages: From Bench to Bedside

  2018cites this paper
• Targeting Costimulatory Pathways in Systemic Sclerosis

  2018cites this paper
• Progresses and Perspectives of Anti-PD-1/PD-L1 Antibody Therapy in Head and Neck Cancers

  2018cites this paper
• Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?

  2018cites this paper
• Interleukin-1 Beta—A Friend or Foe in Malignancies?

  2018influential citation
• Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma

  2018cites this paper
• Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma

  2018cites this paper
• γ‐Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma

  2018influential citation
• Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma

  2018cites this paper
• Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians.

  2018cites this paper
• Trial watch: Immune checkpoint blockers for cancer therapy

  2017cites this paper
• T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer

  2017influential citation
• [Current events in immunotherapy for upper aerodigestive tract cancer].

  2017cites this paper
• Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma

  2017cites this paper
• Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma

  2017cites this paper
• Selective blockade of B7‐H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma

  2017influential citation
• NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma

  2017cites this paper
• c-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma

  2017influential citation
• Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications

  2017cites this paper
• Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma

  2017cites this paper
• Inhibition of SRC family kinases reduces myeloid‐derived suppressor cells in head and neck cancer

  2017cites this paper
• Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-RasG12V–Induced Squamous Tumors

  2017cites this paper
• LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma

  2016cites this paper
• Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

  2015cites this paper
• Digital Commons@Becker Digital

  year unknowncites this paper